	Company Name	Product Name	Treatment Area	Phase	Mechanism of Action	Flags	Pipeline/PDF Url
0	ionis	ionis	['!']	['!']	['!']	['No data found on website!']	http://www.ionispharma.com/pipeline/
1	bayer	bayer	['!']	['!']	['!']	['No data found on website!']	http://pharma.bayer.com/en/innovation-partnering/development-pipeline/
2	biogen	aducanumab	"[""Alzheimer's"", 'disease']"	3	[]	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
3	biogen	BIIB067	['loss', 'ALS', 'disease', 'sclerosis', 'brain']	2	[]	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
4	biogen	Dapirolizumab	['Lupus', 'B', 'inflammatory', 'lupus', 'chronic', 'disease', 'brain']	2	['humanized antibody', 'antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
5	biogen	Opicinumab	['vision', 'loss', 'disease', 'sclerosis', 'virus']	2	[]	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
6	biogen	E2609	"['non-Hodgkin’s', 'loss', 'disease', ""Alzheimer's"", 'brain']"	3	['inhibitor', 'inhibitor)', '(BACE1']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
7	biogen	BIIB074	['lupus', 'disease']	2	['inhibitor)']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
8	biogen	Natalizumab	['Crohn’s', 'acute', 'inflammatory', 'lymphocytic', 'stroke', 'Acute', 'sclerosis', 'ischemic', 'brain', 'Stroke']	2	['humanized antibody', 'inhibitor)']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
9	biogen	Obinutuzumab	['tumors', 'lymphoma', 'B', 'non-Hodgkin’s', 'lymphocytic', 'cancer', 'chronic']	3	['humanized antibody', 'antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
10	biogen	BIIB054	"[""Parkinson's"", 'disease']"	2	[]	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
11	biogen	BAN2401	['disease', 'brain', 'loss']	2	['mAb)', 'antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
12	biogen	Aducanumab	['disease', 'brain', 'loss']	3	['mAb)', 'antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
13	biogen	obinutuzumab	['cancer']	3	['humanized antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
14	biogen	BG00011	['pulmonary', 'Pulmonary', 'fibrosis', 'Idiopathic', 'disease', 'brain']	2	['antibody']	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
15	biogen	BIIB059	['Lupus', 'inflammatory', 'lupus', 'chronic', 'disease', 'brain']	2	[]	[]	https://www.biogen.com/en_us/research-pipeline/biogen-pipeline.html
16	roche	RG6114	['cancer', 'breast']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
17	roche	RG435	['cancer', 'Oncology', 'breast', 'acute']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
18	roche	RG1662	['disorders', 'A', 'brain']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
19	roche	RG7882	['ovarian', 'cancer', 'A']	1	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
20	roche	RG7845	['autoimmune']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
21	roche	RG6100	"[""Alzheimer's"", 'disease']"	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
22	roche	Alectinib	['tumorigenesis', 'disease', 'malignant']	1	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
23	roche	Obinutuzumab	['lupus']	2	['monoclonal']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
24	roche	crenezumab	"[""Alzheimer's"", 'disease']"	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
25	roche	RG7854	['infection', 'B', 'hepatitis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
26	roche	emactuzumab+atezolizumab	['Oncology', 'tumors', 'Cancer']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
27	roche	emactuzumab	['cancer', 'tumors', 'A', 'Cancer']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
28	roche	RG6013	['hemophilia']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
29	roche	cobimetinib+atezolizumab	['Oncology']	1	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
30	roche	cobimetinib+atezolizumab	['Oncology']	3	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
31	roche	cobimetinib	['Oncology', 'Cancer', 'tumours']	1	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
32	roche	cobimetinib	['cancer', 'Oncology', 'breast']	2	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
33	roche	ruxolitinib	['myelofibrosis', 'A', 'fibrosis']	1	['inhibitor', 'tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
34	roche	RG6061	['Oncology', 'tumors']	1	['oligonucleotide']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
35	roche	Pertuzumab	['cancer', 'breast']	3	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
36	roche	RG1273	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
37	roche	RG7880	['inflammatory']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
38	roche	RG6046	['chronic', 'B', 'hepatitis']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
39	roche	RG7861	['conjugate', 'Staphylococcus', 'aureus']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
40	roche	RG7421	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
41	roche	RG7421	['Oncology']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
42	roche	RG7421	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
43	roche	RG7221	['Oncology']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
44	roche	emicizumab	['hemophilia']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
45	roche	ipilimumab	['Oncology', 'tumors', 'Cancer', 'tumours']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
46	roche	Frontline	['chronic', 'lymphocytic']	3	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
47	roche	RG7203	['schizophrenia']	1	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
48	roche	RG6029	['peripheral']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
49	roche	Vanucizumab	['cancer']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
50	roche	Etrolizumab	['disease', 'ulcerative']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
51	roche	RG7741	['tumors', 'lymphoma', 'tumor']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
52	roche	RG6149	['asthma']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
53	roche	codrituzumab	['cancer', 'liver']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
54	roche	RG7413	['bowel', 'disease', 'ulcerative']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
55	roche	azacitidine	['myelodysplastic']	1	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
56	roche	azacitidine	['myelodysplastic']	2	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
57	roche	azacitidine	['acute']	3	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
58	roche	RG7935	"[""Parkinson's"", 'disease']"	1	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
59	roche	RG6083	['atrophy']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
60	roche	RG7686	['cancer', 'Oncology', 'liver']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
61	roche	RG7446+ipilimumab	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
62	roche	RG7446	['ovarian', 'Oncology', 'tumors', 'cancer']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
63	roche	RG7446	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
64	roche	RG6180	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
65	roche	Gantenerumab	"['disease', ""Alzheimer's""]"	3	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
66	roche	nemolizumab	['dermatitis']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
67	roche	lebrikizumab	['pulmonary', 'idiopathic', 'fibrosis', 'dermatitis']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
68	roche	RG7876+atezolizumab	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
69	roche	RG7876+vanucizumab	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
70	roche	RG7876	['Oncology', 'tumors', 'Cancer', 'tumours']	1	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
71	roche	RG7625	['autoimmune']	2	['antagonist']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
72	roche	URC102	['A']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
73	roche	URC102	['gout']	2	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
74	roche	URC102	['A']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
75	roche	RG6078+atezolizumab	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
76	roche	RG6078	['cancer', 'tumors', 'A', 'Cancer']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
77	roche	erlotinib	['Oncology']	1	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
78	roche	RG7992	['gout']	1	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
79	roche	RG1569	['sclerosis']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
80	roche	atezolizumab+obinutuzumab	['Oncology', 'lymphoma', 'Cancer']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
81	roche	atezolizumab+erlotinib	['Oncology']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
82	roche	atezolizumab	['tumors', 'Oncology', 'prostate', 'lymphoma', 'B', 'myelodysplastic', 'Cancer', 'breast', 'cancer', 'A', 'Diabetes', 'tumours']	1	['PD-L1', 'humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
83	roche	atezolizumab	['Oncology', 'prostate', 'breast', 'Cancer', 'cancer', 'ovarian', 'A']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
84	roche	Emicizumab	['hemophilia', 'congenital']	3	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
85	roche	Lampalizumab	['Diseases', 'chronic']	3	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
86	roche	RG7916	['atrophy']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
87	roche	RG6168	['neuromyelitis', 'A']	3	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
88	roche	RG3502	['Oncology']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
89	roche	RG3502	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
90	roche	RG6026	['Oncology', 'lymphoma']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
91	roche	RG6026	['lymphoma', 'myelodysplastic']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
92	roche	obinutuzumab	['Oncology', 'lymphoma', 'Cancer', 'disease', 'A']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
93	roche	obinutuzumab	['lupus', 'A']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
94	roche	RG7440	['cancer', 'Oncology', 'prostate']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
95	roche	Crenezumab	"['disease', ""Alzheimer's""]"	3	['monoclonal']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
96	roche	polatuzumab	['conjugate', 'tumor']	2	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
97	roche	pertuzumab	['cancer']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
98	roche	pertuzumab	['cancer', 'breast']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
99	roche	BRAFv600	['A']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
100	roche	alectinib	['lymphoma', 'Cancer']	1	['tyrosine-kinase inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
101	roche	RG6125	['inflammatory', 'rheumatoid', 'arthritis']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
102	roche	lampalizumab	['atrophy']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
103	roche	Nemolizumab	['dermatitis']	2	['monoclonal', 'interleukin-31', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
104	roche	RG7227	['chronic', 'B', 'hepatitis']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
105	roche	RG6047	['cancer', 'breast']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
106	roche	emtansine+pertuzumab	['Oncology', 'breast']	3	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
107	roche	emtansine	['breast']	2	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
108	roche	emtansine	['conjugate']	3	['chemical substance']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
109	roche	RG7386	['Oncology', 'tumours', 'tumour-cell']	1	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
110	roche	etrolizumab	['disease', 'ulcerative']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
111	roche	HIF-1	['disease']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
112	roche	CSF-1	['A']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
113	roche	RG7159	['Oncology', 'disease']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
114	roche	RG7159	['lupus']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
115	roche	RG6004	['chronic', 'B', 'hepatitis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
116	roche	RG7888+atezolizumab	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
117	roche	RG7888	['tumors', 'A', 'Cancer']	1	['monoclonal']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
118	roche	RG7828	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
119	roche	tocilizumab	['sclerosis', 'vasculitis']	3	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
120	roche	RG6152	['Diseases', 'B', 'A', 'seasonal', 'influenza']	2	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
121	roche	RG7388	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
122	roche	RG7716	['A']	2	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
123	roche	RG6016	['Oncology', 'tumors']	1	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
124	roche	RG7601	['tumor', 'lymphocytic', 'ovarian', 'chronic', 'cancer', 'A']	1	['Bcl-2', 'inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
125	roche	RG7601	['Oncology', 'tumor', 'lymphoma', 'B', 'myelodysplastic', 'A']	2	['Bcl-2', 'inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
126	roche	RG7601	['tumor', 'Oncology', 'acute', 'lymphocytic', 'chronic', 'A']	3	['Bcl-2', 'inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
127	roche	RG7155+RG7876	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
128	roche	Atezolizumab	['cancer', 'A']	1	['antibody', 'monoclonal', 'PD-L1']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
129	roche	Atezolizumab	['cancer', 'tumours']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
130	roche	RG6069	['fibrosis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
131	roche	RG7853	['cancer', 'Oncology', 'breast', 'acute']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
132	roche	RG6146	['cancer', 'Oncology']	1	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
133	roche	bevacizumab	['ovarian', 'tumor', 'A']	1	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
134	roche	ocrelizumab	['sclerosis']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
135	roche	gantenerumab	"[""Alzheimer's"", 'disease']"	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
136	roche	ARN-927	['breast', 'cancer']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
137	roche	RG1450	"[""Alzheimer's"", 'disease']"	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
138	roche	trastuzumab-DM1	['cancer', 'Oncology', 'breast']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
139	roche	RG3637	['pulmonary', 'fibrosis', 'chronic', 'idiopathic', 'disease', 'dermatitis']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
140	roche	RG7813+RG7446	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
141	roche	RG7813	['Oncology', 'tumors', 'A']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
142	roche	atezolizumab.	['Oncology']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
143	roche	RG7204	['Oncology']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
144	roche	RG7417	['atrophy']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
145	roche	RG3616	['pulmonary', 'fibrosis', 'myelofibrosis', 'idiopathic', 'A']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
146	roche	CKI27	['tumors', 'Oncology']	1	['inhibitor', 'MEK']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
147	roche	Lebrikizumab	['pulmonary', 'idiopathic', 'fibrosis', 'dermatitis']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
148	roche	RG6000	['sclerosis', 'amyotrophic']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
149	roche	RG6058	['Oncology', 'tumours']	1	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
150	roche		['tumors', 'Cancer']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
151	roche	vanucizumab	['tumours']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
152	roche	vanucizumab	['cancer']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
153	roche	Trastuzumab	['cancer', 'breast']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
154	roche	RG7907	['infection', 'B', 'hepatitis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
155	roche	RG7834	['chronic', 'B', 'hepatitis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
156	roche	RG7906	['disorders', 'psychiatric']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
157	roche	RG1594	['sclerosis']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
158	roche	RG7745	['virus', 'A', 'influenza']	2	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
159	roche	RG105	['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
160	roche	RG7461	['Oncology', 'A', 'tumours']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
161	roche	RG7604	['Oncology']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
162	roche	RG7604	['cancer', 'breast']	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
163	roche	RG7802	['Oncology', 'tumors', 'tumor']	1	['antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
164	roche	RG3645	['pulmonary', 'chronic', 'disease']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
165	roche	Ocrelizumab	['disease', 'inflammatory', 'sclerosis']	1	['monoclonal', 'antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
166	roche	rituximab	['chronic', 'lymphocytic']	2	['Chimeric antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
167	roche	RG7314	['autism']	2	['antagonist']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
168	roche	trastuzumab	['conjugate']	1	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
169	roche	trastuzumab	['Oncology', 'breast']	2	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
170	roche	trastuzumab	['Oncology', 'breast']	3	['humanized antibody']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
171	roche	RG7412	"[""Alzheimer's"", 'disease']"	3	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
172	roche	RG7990	['asthma']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
173	roche	RG6185	['Oncology']	1	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
174	roche		['Oncology']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
175	roche	GA101	['lupus']	2	['monoclonal']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
176	roche	RG7800	['HPV', 'Oncology', 'infection', 'tumor', 'acute', 'Diseases', 'Cervical', 'Staphylococcus', 'Cancer', 'HIV', 'atrophy', 'cancer', 'MRSA', 'ovarian', 'aureus']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
177	roche	immunocytokine	['tumors', 'A']	1	['antibody', 'cytokine']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
178	roche	OP0595	['Diseases']	1	['inhibitor']	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
179	roche	RG7986	['lymphoma', 'B']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
180	roche	RG6080	['Diseases']	1	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
181	roche	RG7596	['Oncology']	2	[]	[]	http://www.roche.com/research_and_development/who_we_are_how_we_work/pipeline.htm
182	astrazeneca	tralokinumab	['asthma']	3	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
183	astrazeneca	mavrilimumab	['chronic', 'gout', 'rheumatoid', 'arthritis']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
184	astrazeneca	tezepelumab	['COPD', 'dermatitis']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
185	astrazeneca	AZD4831	['heart']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
186	astrazeneca	durvalumab+AZD1775	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
187	astrazeneca	durvalumab+MEDI0562	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
188	astrazeneca	durvalumab+MEDI9447	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
189	astrazeneca	durvalumab+monalizumab	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
190	astrazeneca	durvalumab+selumetinib	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
191	astrazeneca	durvalumab+tremelimumab	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
192	astrazeneca	durvalumab+MEDI0680	['tumours']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
193	astrazeneca	durvalumab+tremelimumab	['cancer']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
194	astrazeneca	durvalumab	['lymphoma']	1	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
195	astrazeneca	durvalumab	['tumours']	2	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
196	astrazeneca	durvalumab	['cancer']	3	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
197	astrazeneca	anifrolumab	['lupus']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
198	astrazeneca	anifrolumab	"['lupus', ""Alzheimer's"", 'disease']"	3	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
199	astrazeneca	MEDI-565	['tumours']	1	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
200	astrazeneca	MEDI9197	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
201	astrazeneca	CTLA-4	['tumours']	1	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
202	astrazeneca	CTLA-4	['cancer']	2	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
203	astrazeneca	AZD1419	['asthma']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
204	astrazeneca	PT010	['asthma']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
205	astrazeneca	PT010	['COPD']	3	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
206	astrazeneca	MEDI5872	['syndrome']	2	['mAb', 'B7RP1']	[]	https://www.astrazeneca.com/our-science/pipeline.html
207	astrazeneca	AZD6738	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
208	astrazeneca	AZD6738	['cancer', 'ovarian']	2	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
209	astrazeneca	monalizumab	['tumours']	1	['PD-L1', 'humanized antibody', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
210	astrazeneca	MEDI4276	['conjugate', 'tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
211	astrazeneca	MEDI4893	['Staphylococcus', 'aureus', 'pneumonia']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
212	astrazeneca	MEDI-573	['cancer', 'breast']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
213	astrazeneca	MEDI6012	['diabetes']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
214	astrazeneca	AZD8871	['COPD']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
215	astrazeneca	MEDI1873	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
216	astrazeneca	AZD4635	['tumours']	1	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
217	astrazeneca	MEDI9447	['tumours']	1	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
218	astrazeneca	SGLT-2	['chronic', 'heart', 'CKD', 'diabetes']	3	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
219	astrazeneca	AZD0156	['Oncology', 'tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
220	astrazeneca	AZD7986	['COPD']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
221	astrazeneca	MEDI5083	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
222	astrazeneca	MEDI0562	['tumours']	1	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
223	astrazeneca	AZD2811	['B', 'tumours']	1	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
224	astrazeneca	selumetinib	['tumours']	1	['tyrosine-kinase inhibitor', 'inhibitor', 'MEK', 'PD-L1']	[]	https://www.astrazeneca.com/our-science/pipeline.html
225	astrazeneca	selumetinib	['cancer', 'prostate', 'breast']	3	['inhibitor', 'tyrosine-kinase inhibitor', 'MEK']	[]	https://www.astrazeneca.com/our-science/pipeline.html
226	astrazeneca	AZD0284	['Respiratory']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
227	astrazeneca	MEDI0680	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
228	astrazeneca	MEDI0680	['tumours']	2	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
229	astrazeneca	AZD5634	['fibrosis']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
230	astrazeneca	MEDI8852	['A', 'influenza']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
231	astrazeneca	MEDI7352	['osteoarthritis']	1	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
232	astrazeneca	MEDI4920	['syndrome']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
233	astrazeneca	IL-13	['asthma', 'COPD']	3	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
234	astrazeneca	MEDI1814	['disease']	1	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
235	astrazeneca	AZD8186	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
236	astrazeneca	GLP-1	['chronic', 'heart', 'diabetes']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
237	astrazeneca	MEDI9314	['dermatitis']	1	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
238	astrazeneca	MEDI8897	['RSV']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
239	astrazeneca	AZD9567	['rheumatoid']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
240	astrazeneca	MEDI3726	['cancer', 'prostate']	1	['antibody']	[]	https://www.astrazeneca.com/our-science/pipeline.html
241	astrazeneca	AZD5363	['cancer', 'breast']	2	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
242	astrazeneca	MEDI3902	['pneumonia']	2	['mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
243	astrazeneca	tremelimumab+MEDI0562	['tumours']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
244	astrazeneca	tremelimumab	['tumours']	1	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
245	astrazeneca	tremelimumab	['cancer']	2	['PD-L1', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
246	astrazeneca	AZD4547	['tumours']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
247	astrazeneca	AZD9496	['cancer', 'breast']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
248	astrazeneca	inebilizumab	['neuromyelitis', 'Neuromyelitis', 'sclerosis']	2	['CD19', 'humanized antibody', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
249	astrazeneca	STAT3	['lymphoma']	1	['inhibitor', 'inhibitor)', 'mAb', 'PD-L1']	[]	https://www.astrazeneca.com/our-science/pipeline.html
250	astrazeneca	AZD1775	['tumours']	1	['inhibitor']	[]	https://www.astrazeneca.com/our-science/pipeline.html
251	astrazeneca	AZD1775	['ovarian', 'cancer', 'tumours']	2	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
252	astrazeneca	AZD4076	['liver']	2	['oligonucleotide']	[]	https://www.astrazeneca.com/our-science/pipeline.html
253	astrazeneca	benralizumab	['asthma', 'COPD']	3	['humanized antibody', 'mAb']	[]	https://www.astrazeneca.com/our-science/pipeline.html
254	astrazeneca	MEDI0700	['lupus']	1	[]	[]	https://www.astrazeneca.com/our-science/pipeline.html
